USPTO serial 98757073
LIFELONG
Reviewed by CopyMark Law Group
Status 807Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HACK, ANDREA R
- Law office
- TMEG LAW OFFICE 108
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LIFELONG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dallas, TX, US
DALLAS, TX, US
Dallas, TX, US
DALLAS, TX, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew T. Pettit
Andrew T. Pettit Perkins Coie LLPP.O. Box 2608Seattle, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software and programs for collecting, processing, analyzing, transmitting, validating and displaying data in the medical, scientific and pharmaceutical fields; downloadable computer software for use in patient relationship management, namely software that facilitates communication and the sharing of data to provide insights into research and care; downloadable computer software for the monitoring of health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use with medical clinical trials, research studies, and clinical trial recruitment; downloadable computer software for data processing and analysis for use with medical clinical trials, research studies, and clinical trial recruitment; downloadable software for managing clinical trials, research studies, and clinical trial recruitment; downloadable software for collecting, storing and analyzing clinical trial data; downloadable computer software and computer programs for transmission of medical and scientific data and information; downloadable software recorded on computer media for use in capture and analysis services to improve patient care; downloadable software for performing healthcare data analytics; downloadable software for authorizing access to databases | ACTIVE | Oct 17, 2025 |
| 035 | Promoting public interest and awareness in the fields of medicine, science, pharmaceuticals and technology; managed care services, namely, electronic processing of healthcare information; data processing services in the field of healthcare; health care utilization and review services; updating and maintaining information in patient data registries; patient relationship management services | ACTIVE | Oct 17, 2025 |
| 038 | Providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data | ACTIVE | Oct 17, 2025 |
| 042 | Providing non-downloadable software on-line for use in providing health care information; providing non-downloadable software online for use in patient relationship management; providing non-downloadable software on-line for use in capture and analysis services to improve patient care; providing temporary use of online non-downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data in the medical, scientific and pharmaceutical fields; providing temporary use of online non-downloadable software for use in patient relationship management, namely, software that facilitates communication and the sharing of data to provide insights into research and care; providing temporary use of online non-downloadable software for the monitoring of health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use with medical clinical trials, research studies, and clinical trial recruitment; providing temporary use of online non-downloadable software for data processing and analysis for use with medical clinical trials, research studies, and clinical trial recruitment; providing temporary use of online non-downloadable software for managing clinical trials, research studies, and clinical trial recruitment; providing temporary use of online non-downloadable software for collecting, storing and analyzing clinical trial data; providing temporary use of online non-downloadable software for transmission of medical and scientific data and information; providing temporary use of non-downloadable software for use in capture and analysis services to improve patient care; providing temporary use of online non-downloadable software for performing healthcare data analytics medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of medical and scientific diagnostic and therapeutic development; scientific laboratory services; clinical laboratory services; scientific laboratory services, namely, laboratory research, analysis and testing services; scientific laboratory services, namely, laboratory storage and testing services; providing medical and scientific research information; consulting services in the field of scientific, medical and pharmaceutical research; providing medical research, scientific, and pharmaceutical research information; scientific study in the field of treatment and management of illnesses over a long-term period of time; scientific research, namely, compiling and analyzing statistic health data gathered from scientific research; long-term health monitoring research; clinical health research; providing online non-downloadable software for authorizing access to databases; collection and analysis of patient health data for healthcare providers for research purposes | ACTIVE | Oct 17, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Verily Life Sciences, LLC
- Other trademarks owned by VERILY HEALTH INC.
- Other trademarks owned by Verily Life Sciences, LLC
- Other trademarks owned by VERILY HEALTH INC.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named LIFELONG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 5, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 5, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 4, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 10, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 6, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 24, 2026 | IUAF | USE AMENDMENT FILED | — |
| Feb 24, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 7, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 12, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 12, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 1, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 1, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 1, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 1, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 26, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 26, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 26, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 11, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 11, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 11, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 18, 2024 | NWAP | NEW APPLICATION ENTERED | — |